Get started
Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series ABruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series ABruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A



Key stats


Market capitalization
‪9.38 B‬ USD
Dividend yield (indicated)
3.49%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.70 USD
Net income (FY)
‪−8.60 M‬ USD
Revenue (FY)
‪3.44 B‬ USD
Shares float
‪111.00 M‬
Beta (1Y)
1.13

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪11.09 K‬
Change (1Y)
−311−2.73%
Revenue / Employee (1Y)
‪310.01 K‬ USD
Net income / Employee (1Y)
−775.82 USD

Company info


Sector
Health Technology
Industry
Medical Specialties
CEO
Frank H. Laukien
Website
bruker.com
Headquarters
Billerica
Founded
1960
ISIN
US1167942077
CUSIP
116794207
FIGI
BBG01X1L3C62
Identifiers
ISIN US1167942077
CFI code
EFVXFR
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI NANO, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI NANO segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Günther Laukien in 1960 and is headquartered in Billerica, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


PFF
iShares Preferred and Income Securities ETF
Weight0.60%
Market value‪75.88 M‬
PFXF
VanEck Preferred Securities ex Financials ETF
Weight1.31%
Market value‪31.24 M‬
PFFD
Global X U.S. Preferred ETF
Weight1.07%
Market value‪22.38 M‬
CWB
State Street SPDR Bloomberg Convertible Securities ETF
Weight0.26%
Market value‪14.52 M‬
SPFF
Global X SuperIncome Preferred ETF
Weight4.28%
Market value‪6.02 M‬
FCVT
First Trust SSI Strategic Convertible Securities ETF
Weight0.49%
Market value‪515.42 K‬
CVRT
Calamos Convertible Equity Alternative ETF
Weight0.94%
Market value‪395.42 K‬

Explore more ETFs 

Frequently asked questions


The current price of BRKRP is 439.16 USD — it has decreased by −0.47% in the past 24 hours. Watch Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A stocks are traded under the ticker BRKRP.
BRKRP stock has risen by 12.34% compared to the previous week, the month change is a 4.60% rise, over the last year Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A has showed a 61.19% increase.
BRKRP reached its all-time high on Jul 30, 2026 with the price of 474.99 USD, and its all-time low was 250.00 USD and was reached on Sep 8, 2025. View more price dynamics on BRKRP chart.
See other stocks reaching their highest and lowest prices.
BRKRP stock is 3.49% volatile and has beta coefficient of 1.13. Track Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A stock price on the chart and check out the list of the most volatile stocks — is Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A there?
Today Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A has the market capitalization of ‪9.33 B‬, it has increased by 16.58% over the last week.
Yes, you can track Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A financials in yearly and quarterly reports right on TradingView.
Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
BRKRP earnings for the last quarter are 0.49 USD per share, whereas the estimation was 0.38 USD resulting in a 27.32% surprise. The estimated earnings for the next quarter are 0.42 USD per share. See more details about Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A earnings.
Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A revenue for the last quarter amounts to ‪838.50 M‬ USD, despite the estimated figure of ‪853.57 M‬ USD. In the next quarter, revenue is expected to reach ‪867.38 M‬ USD.
BRKRP net income for the last quarter is ‪−52.00 M‬ USD, while the quarter before that showed ‪14.40 M‬ USD of net income which accounts for 0.00% change. Track more Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A financial stats to get the full picture.
Yes, BRKRP dividends are paid quarterly. The last dividend per share was 3.98 USD. As of today, Dividend Yield (TTM)% is 0.33%. Tracking Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A dividends might help you take more informed decisions.
As of Sep 23, 2026, the company has ‪11.09 K‬ employees. See our rating of the largest employees — is Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A EBITDA is ‪529.10 M‬ USD, and current EBITDA margin is 14.56%. See more stats in Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A financial statements.
Like other stocks, BRKRP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A stock shows the sell signal. See more of Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A technicals for a more comprehensive analysis.